
Advertise on podcast: USF Health’s IDPodcasts
Rating
4.4from
This podcast has
215 episodes
Language
EnglishPublisher
IDPodcastsExplicit
No
Date created
2009/02/23
Latest episode
2026/11/06
Average duration
57 min.
Release period
14 days
Description
From the University of South Florida Division of Infectious Diseases and International Medicine. Enjoy our collection of infectious diseases podcasts, featuring medical presentations from our USF Health faculty, fellows and other guest presenters oriented for healthcare professionals, medical students, residents, and other clinicians. New episodes are usually available weekly. For more information, visit IDPodcasts.net.
Unlock USF Health’s IDPodcasts podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from USF Health’s IDPodcasts podcast
Hansen’s Disease/Leprosy
2026/11/06
Dr. Beata Casañas, Professor of Medicine at the Morsani College of Medicine, discusses leprosy, or Hansen’s disease, one of the earliest recorded diseases that is still affecting people in the modern era of medicine. Dr. Casañas begins by discussing the history of of leprosy, from its origins in ancient history, to the discovery of the M. leprae bacillus, to the modern era of treatment. Next, she discusses the current epidemiology of Hansen’s, including the hotspot’s worldwide and the populations and groups most often affected. Moving on, the pathophysiology of the disease is discussed, followed by classification schedules, diagnosis, and treatment, which can have important side effects. Lastly, Dr. Casañas discusses national resources for assisting the clinician with management, including the National Hansen’s Disease Program.
PrEP for the Prevention of HIV Infection
2026/10/30
Dr Lauren Rybolt, Assistant Professor of Medicine, of the USF Division of Infectious Diseases, Morsani College of Medicine, discusses the latest updates in pre-exposure prophylaxis for the prevention of HIV Infection in susceptible at risk individuals. Dr. Rybolt begins by discussing the at risk population, and who best qualifies for PrEP. She then goes on to discuss the available options for therapy, including daily oral and injectable options. Finally, testing and management interventions to help boost compliance with therapy are reviewed.
Anal Cancer Screening Implementation
2026/10/19
Dr. Patrick Danaher, Professor of Medicine at the Morsani College of Medicine, discusses how to set up an anal cytology screening program for high risk patients for an outpatient clinic. Dr. Danaher begins by discussing the epidemiology and pathophysiology of rectal dysplasia. He then shares clinical trial data on the benefits of this screening program. Rectal cancer screening guidelines are next presented. Dr. Danaher then goes over the steps necessary to collect rectal cytology, and also presents several clinically relevant case studies to help the listener absorb the information presented.
HIV in Older Patients
2026/10/09
Dr. Todd Wills, Professor of Medicine with the Morsani College of Medicine at the University of South Florida, reviews the unique complications and issues that can occur in the elderly HIV patient. Dr. Wills begins by reviewing the epidemiology of HIV by age group, including the fact that the HIV positive population is growing older with time. Dr. Wills also discusses issues regarding polypharmacy and medication tolerability in the older patient. Next, the speaker relates how the high prevalence of chronic diseases affect the HIV positive patient’s prognosis. HIV positive elderly patients can suffer not just from frailty, but from cardiovascular disease, diabetes, osteoporosis, and cancer. Dementia can also affect an elderly HIV paitent’s overall wellness and compliance with antiviral therapy. Dr. Wills also covers the assessment of bone density in elderly HIV positive patients. Lastly, Dr. Wills discusses HIV positive patient life expectancy in the modern age of antiretroviral therapy. The lecture is updated for 2026.
Non-Tuberculous Mycobacteria: The Undiscovered Country
2026/09/15
Dr. Anthony Cannella, Director of the Non-Tuberculous Mycobacerial clinic at Moffitt Cancer Center and Research Institute, provides an overview of the management of AFB infections in both immunocompromised and non-immunocompromised patients. Topics discussed include the epidemiology of NTM infections, environmental risk factors, the immunological basis of infection, risk factors, clinical presentation, and treatment options. Treatment topics include traditional and newer treatment options, the use of aminoglycosides, clofazamine, dual beta-lactam therapy, and the oxazolidinones.
Immunizations in HIV Care
2026/09/03
Dr. Shylah Moore-Pardo, Assistant Professor with the Division of Infectious Diseases and International Medicine, reviews the basics regarding vaccinations in the HIV-positive population. Dr. Pardo first reviews routine immunizations, such as Influenza, Tetanus, and COVID-19. She then covers risk specific vaccines, such as shots for Hepatitis B and C, meningococcus, and Mpox. Next, Dr. Pardo discusses routine vaccines indicated based upon one’s age, including Shingles, HPV, and pneumococcus. She then reviews non-routine vaccines given as indicated (Rabies, Men-B, Travel vaccines, etc.).
The Basics of Antimicrobial Dosing
2026/08/28
Kristen Greene, Nicholas Piccicacco, and Mel O’Neal, ID Clinical Pharmacists at Tampa General Hospital, present an overview of antimicrobial dosing strategies to optimize efficacy and effectiveness of these therapies. Topics covered include pharmacokinetics, pharmacodynamics, vancomycin dosing, the importance of drug binding, dosing in renal insufficiency, and Beta-lactam allergies.
What To Do With a Positive Blood Culture
2026/08/10
Dr. Richard Oehler, Professor of Medicine at the Division of Infectious Diseases/USF Morsani College of Medicine, presents a review of bacteremia. Dr. Oehler begins by reviewing the epidemiology, personal and institutional costs of bacteremia. He then discusses blood culture collection and how false positive blood cultures occur. Next, Dr. Oehler reviews automated blood culture systems and multiplex PCR and MALDI-TOF technology. The speaker then contrasts gram positive and gram negative bacteremia in general and by organism. The management of a positive blood culture with regard to treatment and source control is discussed. Lastly, ways to reduce the incidence of bacteremia are shared.
Infections in Hematologic Malignancies and Stem Cell Transplantation
2026/08/04
Dr. Olga Klinkova, Infectious Diseases Physician at the Moffitt Cancer Center and Research Institute, presents an introductory session on the management of the immunocompromised patient. Dr. Klinkova begins by explaining the major immune deficits in patients with hematologic malignancy and stem cell transplantation (SCT). She then outlines the likely pathogens that produce infections based on the timeline after cancer therapy or SCT. She further explains the major pulmonary syndromes seen in hematologic malignancies and transplant. Lastly, she discusses infections that can occur after CAR-T therapies as well as CMV infection post-transplant.
Microbiology 101
2026/07/21
Dr. Suzane Silbert, Director of Tampa General Hospital’s Microbiology laboratory, presents an introductory lecture on the modern infectious diseases laboratory. Topics covered include basic microorganism classification schemes, basic microscopy, E tests, culture techniques, mass spectroscopy, PCR assays, and other molecular technology. Syndromic multiplex panels are also mentioned. The lecture is suitable for medical trainees, medical residents, and infectious diseases fellows.
ID Board Review: Peds, Pregnancy, Parasites, Protozoa and Prophylaxis
2026/07/02
Dr. Shylah Moore-Pardo, associate program director of the ID fellowship program at the Morsani College of Medicine, conducts this interactive board review suitable for Medical Students, Residents, and Fellows. Five different categories of questions are covered.
Candida Infections Board Review
2026/06/12
Dr. Olga Klinkova, Infectious Diseases clinician at Moffitt Cancer Center and Research Institute, conducts a board review session on Candida Infections targeted towards the medical resident or Infectious Diseases Fellow. Topics discussed include a comparison and contrast of the different Candida species, information on Candida auris, Candidemia, and disseminated (hepatosplenic) candidiasis. Also discussed are novel antifungals used for azole-resistant candidiasis. Guidelines based reference sources are also mentioned.
Antimicrobial Side Effects: The Zebras, Not the Horses
2026/06/08
Dr. Yanina Pasikhova, Infectious Diseases Pharmacist at Moffitt Cancer Center and Research Institute, presents a talk on three lesser well known adverse drug effects involving antimicrobials. Dr. Pasikhova discusses the link between voriconazole and bone pain, the association between posaconazole and refractory hypertension and hypokalemia, and the neurological effects of of metronidazole therapy. Clinical pearls are provided for each interaction discussed.
Rickettsial Infections
2026/05/22
Dr. Medaris, Chief of Infectious Diseases at Bay Pines Medical Center in St. Petersburg, Florida, conducts a review of Rickettsial Infections. After starting with an overview of the genus Rickettsia, Dr. Medaris moves on to discuss Rocky Mountain Spotted Fever, R. Parkeri, Mediterranean Spotted Fever, and Rickettsial Pox. African Tick Bite Fever is next discussed, followed by Sylvatic and Murine Typhus. Lastly, Dr. Medaris discusses Coxiella infections. Though not strictly a Rickettsiosis, it shares similarities with the Rickettsial group. The lecture is suitable for board review or for gaining further knowledge regarding these unusual pathogens.
PrEPare for a PEP Talk
2026/05/04
Dr. Drew Wilson, ID Pharmacy Resident, discusses the new options for pre-exposure prophylaxis (PrEP) to prevent HIV infection. Options discussed include oral PrEP (Truvada, Descovy), cabotegravir, and a newer option, lenacapravir. A prescribing algorithm is also presented, and the topic of developing resistance is also covered. Lastly, Dr. Wilson touches upon other novel agents for PrEP, as well as DoxyPEP for the prevention of bacterial STIs.
Podcast reviews
Read USF Health’s IDPodcasts podcast reviews
Good Medicine Podcasts 2023/11/16
Good_Medicine_Podcasts
This has become a go to podcast for me for general infectious disease review. Excellent content for the general internist or hospitalist.
doc pat99 2020/02/07
Excellent
Excellent content ...but some episodes I can’t play especially the episodes in the 2 Nd half of 2019 - please fix thanks
Podcast sponsorship advertising
Start advertising on USF Health’s IDPodcasts relevant audience podcasts
You may also like to advertise on these Podcasts

4.116097472
The Tucker Carlson Show
Tucker Carlson Network

4.828116459
Huberman Lab
Scicomm Media

4.240683
To Be The Man
Podcast Heat | Cumulus Podcast Network

4.41511762000
The Ben Shapiro Show
The Daily Wire

4.2155648
TENNIS.com Podcast
TENNIS.com Podcast/Tennis Channel Podcast Network

4.510882780
The Joe Budden Podcast
The Joe Budden Network

4.611699506
The Bulwark Podcast
The Bulwark

4.711532393
Matt and Shane's Secret Podcast
Matt McCusker & Shane Gillis

4.72580183
Smosh Reads Reddit Stories
Smosh

4.975278756
Small Town Murder
James Pietragallo, Jimmie Whisman